220 related articles for article (PubMed ID: 7929799)
1. Anti-GM1 antibodies in patients with chronic inflammatory demyelinating polyneuropathy (CIDP) treated with intravenous immunoglobulin (IVIg).
van Schaik IN; Vermeulen M; van Doorn PA; Brand A
J Neuroimmunol; 1994 Oct; 54(1-2):109-15. PubMed ID: 7929799
[TBL] [Abstract][Full Text] [Related]
2. Serum and CSF anti-GM1 antibodies in patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.
Simone IL; Annunziata P; Maimone D; Liguori M; Leante R; Livrea P
J Neurol Sci; 1993 Jan; 114(1):49-55. PubMed ID: 8433097
[TBL] [Abstract][Full Text] [Related]
3. Demyelinating symmetric motor polyneuropathy with high titers of anti-GM1 antibodies.
O'Ferrall EK; White CM; Zochodne DW
Muscle Nerve; 2010 Oct; 42(4):604-8. PubMed ID: 20730877
[TBL] [Abstract][Full Text] [Related]
4. [Antibodies to GM1 ganglioside in motor neuron disease--in comparison with demyelinating neuropathy].
Irie S; Saito T; Ogino M; Ito H; Kowa H
Rinsho Shinkeigaku; 1992 Oct; 32(10):1075-80. PubMed ID: 1297550
[TBL] [Abstract][Full Text] [Related]
5. Temporal profile of anti-ganglioside antibodies and their relation to clinical parameters and treatment in Guillain-Barré syndrome.
Press R; Matá S; Lolli F; Zhu J; Andersson T; Link H
J Neurol Sci; 2001 Sep; 190(1-2):41-7. PubMed ID: 11574105
[TBL] [Abstract][Full Text] [Related]
6. High anti-GM1 and anti-GD1a IgG antibody titers are detected in Guillain-Barré syndrome but not in chronic inflammatory demyelinating polyneuropathy.
Tagawa Y; Yuki N; Hirata K
Eur Neurol; 2002; 48(2):118-9. PubMed ID: 12187004
[No Abstract] [Full Text] [Related]
7. Demyelinating symmetric motor polyneuropathy with high anti-GM1 antibody titer: do we need to split?
Galassi G
Muscle Nerve; 2011 Jul; 44(1):147-8; author reply 148. PubMed ID: 21660986
[No Abstract] [Full Text] [Related]
8. Association of IgM type anti-GM1 antibodies and muscle strength in chronic acquired demyelinating polyneuropathy.
Bech E; Andersen H; Orntoft TF; Jakobsen J
Ann Neurol; 1998 Jan; 43(1):72-8. PubMed ID: 9450770
[TBL] [Abstract][Full Text] [Related]
9. Intravenous immunoglobulin treatment in patients with chronic inflammatory demyelinating polyneuropathy.
van Doorn PA
J Neurol Neurosurg Psychiatry; 1994 Nov; 57 Suppl(Suppl):38-42. PubMed ID: 7964851
[TBL] [Abstract][Full Text] [Related]
10. Chronic inflammatory demyelinating polyneuropathy: clinical features and response to treatment in 67 consecutive patients with and without a monoclonal gammopathy.
Gorson KC; Allam G; Ropper AH
Neurology; 1997 Feb; 48(2):321-8. PubMed ID: 9040714
[TBL] [Abstract][Full Text] [Related]
11. Multifocal motor neuropathy. Serum IgM anti-GM1 ganglioside antibodies in most patients detected using covalent linkage of GM1 to ELISA plates.
Pestronk A; Choksi R
Neurology; 1997 Nov; 49(5):1289-92. PubMed ID: 9371910
[TBL] [Abstract][Full Text] [Related]
12. High-titer selective serum anti-beta-tubulin antibodies in chronic inflammatory demyelinating polyneuropathy.
Connolly AM; Pestronk A; Trotter JL; Feldman EL; Cornblath DR; Olney RK
Neurology; 1993 Mar; 43(3 Pt 1):557-62. PubMed ID: 8451001
[TBL] [Abstract][Full Text] [Related]
13. Distal acquired demyelinating symmetric neuropathy associated with anti-GM1 antibodies: is this a CIDP variant?
Remiche G; Kentos A; Mavroudakis N
Acta Neurol Belg; 2010 Mar; 110(1):103-6. PubMed ID: 20514936
[TBL] [Abstract][Full Text] [Related]
14. Clinical correlations of anti-GM1 antibodies in amyotrophic lateral sclerosis and neuropathies.
Lamb NL; Patten BM
Muscle Nerve; 1991 Oct; 14(10):1021-7. PubMed ID: 1944401
[TBL] [Abstract][Full Text] [Related]
15. [High-dose intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy].
Tomiyama M; Baba M; Matsunaga M; Takada H; Okushima T; Narita S; Takebe K
No To Shinkei; 1992 Nov; 44(11):979-82. PubMed ID: 1296721
[TBL] [Abstract][Full Text] [Related]
16. IVIG blocks complement deposition mediated by anti-GM1 antibodies in multifocal motor neuropathy.
Yuki N; Watanabe H; Nakajima T; Späth PJ
J Neurol Neurosurg Psychiatry; 2011 Jan; 82(1):87-91. PubMed ID: 20667861
[TBL] [Abstract][Full Text] [Related]
17. [A case of chronic inflammatory demyelinating polyneuropathy with recurrent ophthalmoplegia, persistent conduction block, antibody activity against gangliosides GM1].
Ryo M; Saito T; Kunii N; Hasegawa H; Kowa H
Rinsho Shinkeigaku; 1994 Jul; 34(7):702-6. PubMed ID: 7955728
[TBL] [Abstract][Full Text] [Related]
18. High-dose intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy: a double-blind, placebo-controlled, crossover study.
van Doorn PA; Brand A; Strengers PF; Meulstee J; Vermeulen M
Neurology; 1990 Feb; 40(2):209-12. PubMed ID: 2405291
[TBL] [Abstract][Full Text] [Related]
19. [Clinical factors relating to the presence of serum anti-GM1 and GD1b antibodies in demyelinating neuropathy--study using a multivariate analysis].
Irie S; Saito T; Kanazawa N; Ito H; Kowa H
Rinsho Shinkeigaku; 1994 May; 34(5):454-60. PubMed ID: 7924057
[TBL] [Abstract][Full Text] [Related]
20. Immunological investigation of chronic inflammatory demyelinating polyradiculoneuropathy.
Meléndez-Vásquez C; Redford J; Choudhary PP; Gray IA; Maitland P; Gregson NA; Smith KJ; Hughes RA
J Neuroimmunol; 1997 Mar; 73(1-2):124-34. PubMed ID: 9058768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
